Literature DB >> 21135555

Serum brain-derived neurotrophic factor levels are specifically associated with memory performance among Alzheimer's disease cases.

Sid E O'Bryant1, Valerie L Hobson, James R Hall, Robert C Barber, Song Zhang, Leigh Johnson, Ramon Diaz-Arrastia.   

Abstract

AIMS: Our purpose was to study the link between serum brain-derived neurotrophic factor (BDNF) levels and neuropsychological functioning through the Texas Alzheimer's Research Consortium cohort.
METHODS: A total of 399 participants [probable Alzheimer's disease (AD) n = 198, controls n = 201] were available for analysis. The BDNF levels were assayed via multiplex immunoassay. Regression analyses were utilized to examine the relation between BDNF levels and neuropsychological functioning.
RESULTS: There were no significant mean differences in BDNF levels between cases and controls. In the AD group, the BDNF levels were significantly negatively associated with the scores on immediate [B = -0.07 (0.02), t = -3.55, p = 0.001] and delayed [B = -0.05 (0.02), t = -2.79, p = 0.01] verbal memory and immediate [B = -0.12 (0.05), t = -2.70, p = 0.01] visual memory. No other neuropsychological variables were significantly related to the BDNF levels. The BDNF levels were not significantly related to the neuropsychological test scores in the control group.
CONCLUSIONS: Increased serum BDNF levels were associated with poorer visual and verbal memory, but only among AD cases. The current findings point toward an upregulation of serum BDNF as one possible mechanism linked to memory disturbances in AD though it does not appear to be linked to disease severity.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21135555      PMCID: PMC3019366          DOI: 10.1159/000321980

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  24 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Dementia and Alzheimer disease incidence: a prospective cohort study.

Authors:  Walter A Kukull; Roger Higdon; James D Bowen; Wayne C McCormick; Linda Teri; Gerard D Schellenberg; Gerald van Belle; Lance Jolley; Eric B Larson
Journal:  Arch Neurol       Date:  2002-11

3.  An examination of the Boston Naming Test: calculation of "estimated" 60-item score from 30- and 15-item scores in a cognitively impaired population.

Authors:  Valerie L Hobson; James R Hall; Michelle Harvey; C Munro Cullum; Laura Lacritz; Paul J Massman; Stephen C Waring; Sid E O'Bryant
Journal:  Int J Geriatr Psychiatry       Date:  2011-04       Impact factor: 3.485

4.  Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease.

Authors:  R M Holsinger; J Schnarr; P Henry; V T Castelo; M Fahnestock
Journal:  Brain Res Mol Brain Res       Date:  2000-03-29

5.  Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

Authors:  Steven T DeKosky; Milos D Ikonomovic; Scot D Styren; Laurel Beckett; Stephen Wisniewski; David A Bennett; Elizabeth J Cochran; Jeffrey H Kordower; Elliott J Mufson
Journal:  Ann Neurol       Date:  2002-02       Impact factor: 10.422

6.  Essential role of brain-derived neurotrophic factor in adult hippocampal function.

Authors:  Lisa M Monteggia; Michel Barrot; Craig M Powell; Olivier Berton; Victor Galanis; Terry Gemelli; Sven Meuth; Andreas Nagy; Robert W Greene; Eric J Nestler
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

7.  BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study.

Authors:  Pirjo Komulainen; Maria Pedersen; Tuomo Hänninen; Helle Bruunsgaard; Timo A Lakka; Miia Kivipelto; Maija Hassinen; Tuomas H Rauramaa; Bente K Pedersen; Rainer Rauramaa
Journal:  Neurobiol Learn Mem       Date:  2008-09-06       Impact factor: 2.877

8.  The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.

Authors:  Michael F Egan; Masami Kojima; Joseph H Callicott; Terry E Goldberg; Bhaskar S Kolachana; Alessandro Bertolino; Eugene Zaitsev; Bert Gold; David Goldman; Michael Dean; Bai Lu; Daniel R Weinberger
Journal:  Cell       Date:  2003-01-24       Impact factor: 41.582

9.  Brain-derived neurotrophic factor levels in Alzheimer's disease.

Authors:  Sid E O'Bryant; Valerie Hobson; James R Hall; Stephen C Waring; Wenyan Chan; Paul Massman; Laura Lacritz; C Munro Cullum; Ramon Diaz-Arrastia
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

10.  Learning deficits in forebrain-restricted brain-derived neurotrophic factor mutant mice.

Authors:  J A Gorski; S A Balogh; J M Wehner; K R Jones
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

View more
  31 in total

1.  Multimodal physical activity increases brain-derived neurotrophic factor levels and improves cognition in institutionalized older women.

Authors:  Kelem Vedovelli; Bruno Lima Giacobbo; Márcio Silveira Corrêa; Andréa Wieck; Irani Iracema de Lima Argimon; Elke Bromberg
Journal:  Geroscience       Date:  2017-07-13       Impact factor: 7.713

2.  Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis.

Authors:  Bo Yi Kim; Seon Heui Lee; Petra L Graham; Francesco Angelucci; Alejandro Lucia; Helios Pareja-Galeano; Thomas Leyhe; Yuda Turana; I Re Lee; Ji Hye Yoon; Jae Il Shin
Journal:  Mol Neurobiol       Date:  2016-11-04       Impact factor: 5.590

3.  Biomarkers of Alzheimer's disease among Mexican Americans.

Authors:  Sid E O'Bryant; Guanghua Xiao; Melissa Edwards; Michael Devous; Veer Bala Gupta; Ralph Martins; Fan Zhang; Robert Barber
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

4.  Associations Between ApoEε4 Carrier Status and Serum BDNF Levels--New Insights into the Molecular Mechanism of ApoEε4 Actions in Alzheimer's Disease.

Authors:  Yu-Hui Liu; Shu-Sheng Jiao; Ye-Ran Wang; Xian-Le Bu; Xiu-Qing Yao; Yang Xiang; Qing-Hua Wang; Lin Wang; Juan Deng; Jing Li; Xin-Fu Zhou; Hua-Dong Zhou; Yan-Jiang Wang
Journal:  Mol Neurobiol       Date:  2014-07-02       Impact factor: 5.590

5.  Apathy and APOE4 are associated with reduced BDNF levels in Alzheimer's disease.

Authors:  Antón Alvarez; Manuel Aleixandre; Carlos Linares; Eliezer Masliah; Herbert Moessler
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

6.  Lack of an association of BDNF Val66Met polymorphism and plasma BDNF with hippocampal volume and memory.

Authors:  Ana Kim; Anne M Fagan; Alison M Goate; Tammie L S Benzinger; John C Morris; Denise Head
Journal:  Cogn Affect Behav Neurosci       Date:  2015-09       Impact factor: 3.282

7.  Plasma BDNF levels are correlated with aggressiveness in patients with amnestic mild cognitive impairment or Alzheimer disease.

Authors:  Tomoyuki Nagata; Nobuyuki Kobayashi; Shunichiro Shinagawa; Hisashi Yamada; Kazuhiro Kondo; Kazuhiko Nakayama
Journal:  J Neural Transm (Vienna)       Date:  2013-11-20       Impact factor: 3.575

8.  Brain-Derived Neurotrophic Factor in Alzheimer's Disease: Risk, Mechanisms, and Therapy.

Authors:  Jing-Hui Song; Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-10-30       Impact factor: 5.590

9.  Molecular neuropsychology: creation of test-specific blood biomarker algorithms.

Authors:  Sid E O'Bryant; Guanghua Xiao; Robert Barber; C Munro Cullum; Myron Weiner; James Hall; Melissa Edwards; Paula Grammas; Kirk Wilhelmsen; Rachelle Doody; Ramon Diaz-Arrastia
Journal:  Dement Geriatr Cogn Disord       Date:  2013-01-03       Impact factor: 2.959

10.  Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer's disease: a meta-analysis study (N=7277).

Authors:  X-Y Qin; C Cao; N X Cawley; T-T Liu; J Yuan; Y P Loh; Y Cheng
Journal:  Mol Psychiatry       Date:  2016-04-26       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.